(MEMPHIS, Tenn. – March 12, 2026) – St. Jude Children’s Research Hospital today announced the appointment of Carsten Bönnemann, MD, as a faculty member to lead and chair the hospital’s newly created ...

General Atlantic, Aquitaine Capital, Avesi Partners and PPC Enterprises are among the PE firms investing in pediatric speech ...

Pediatric brain disorders remain one of the most challenging areas in modern healthcare, affecting millions of children worldwide through conditions such as epilepsy, hydrocephalus, brain tumors, ...

Scientists use DNA methylation patterns as a roadmap for identifying causes of severe epilepsies in children. To effectively treat a disease or disorder, doctors must first know the root cause. Such ...

Most neuropathic pain randomized controlled trials include psychiatric exclusion criteria, limiting generalizability for a highly affected population.

Seizures in children are often linked to epilepsy, but medical experts caution that not every seizure is necessarily due to ...

WEST CHESTER, PA — Pathways Neuro Pharma Inc. has announced a significant pivot in its development pipeline, prioritizing rare pediatric neurological disorders, with Juvenile Parkinson’s Disease (JPD) ...

Stroke, Alzheimer's disease (AD), and other neurologic conditions are now the leading cause of health loss and disability around the world, affecting nearly half of the world's population, a new ...

St. Jude Children's Research Hospital is leading the way the world understands, treats, and cures childhood catastrophic diseases. From cancer to life-threatening blood disorders, neurological ...